Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

U S Physical Therapy Q3 2026 Results: Net Income $11M, Down 15.9% YoY

U.S. Physical Therapy, Inc. reported net revenue of $634.9 million for the nine months ended September 30, 2026, an increase from $578.3 million in the prior year. However, net income attributable to shareholders decreased to $26.0 million from $35.4 million, primarily due to higher operating costs and a loss on the change in fair value of contingent earn-out consideration.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue222.6197.1
Gross profit43.036.9
Profit before tax21.622.9
Net income11.013.1
EPS (diluted, $ a share)$-1.04$0.48

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-15.9%
Revenue, year on year+12.9%
Gross margin19.3%
Operating margin11.3%
Source

10-Q filed with the SEC, NYSE: USPH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

U S Physical Therapy Inc: key numbers

Share price
$99.55Close, Nov 16
Market cap
$1.49B
Shares outstanding
14.93MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Health ServicesSIC 8000

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from U S Physical Therapy Inc

All →
4:25 PM ET 8-K
Financial Results

U S Physical Therapy Financial Results

U.S. Physical Therapy hosted an earnings call to discuss its financial results for the third quarter and nine months ended September 30, 2026. The company reported record volume with 27 consecutive months of record visits and successfully transitioned its Metro New York facilities into the NYU Langone hospital partnership.

Term
Q3 2026

“With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred, nearly 2.5 years of record volume each and every month.”

Chris Reading, Chairman and CEO
4:12 PM ET 8-K
Financial Results

U S Physical Therapy Financial Results

U.S. Physical Therapy, Inc. reported its financial results for the period ended September 30, 2026. The filing was made under Item 2.02, which is the standard SEC disclosure for quarterly or annual results of operations and financial condition.

5:09 PM ET 8-K
Loan & Debt

U S Physical Therapy $171M Debt Financing with Bank of America, National Association

U.S. Physical Therapy, Inc. entered into a 45-month forward-starting interest rate swap agreement with Bank of America with an initial notional amount of $170.6 million. The swap fixes the variable interest rate on the company's existing term debt at 4.578% per annum effective June 30, 2027, through April 14, 2031. This transaction is designed to hedge interest rate risk associated with the company's Fourth Amended and Restated Credit Agreement.

Value
$171M
Counterparty
Bank of America, National Association
Term
45 months
4:20 PM ET 8-K
Leadership Change

U S Physical Therapy Leadership Change

U.S. Physical Therapy, Inc. has appointed Myra Davis to its Board of Directors, effective October 1, 2026. Ms. Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and brings over two decades of healthcare technology leadership experience to the board.

Counterparty
Myra Davis

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.